A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

New use of gabapentin (Neurontin) was not associated with greater risk of falls in older adults with neuropathy or ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

According to the results of a new study, “cannabis-based medicines may be effective in treating the pain and symptoms of ...

Starting next year, Medicare recipients will see a $2,000 out-of-pocket cap on some prescription drugs as part of several new provisions coming in 2025. Starting in 2025, Medicare recipients will ...

Lower back pain can affect one's ability to move comfortably and function throughout the day. Medications, including over-the-counter (OTC) and prescription drugs, are available to manage pain and ...

The drug costs just pennies to make but can sell for up to $20 for a single tablet. The haul seen at the abandoned factory is potentially worth tens of millions of dollars. For years, neighboring ...

therefore providing dogs with some relief from pain. A U.S. study of 272 dogs with osteoarthritis found that 47.4 percent of dogs receiving the drug showed improvement after the first shot ...

The FDA on Monday notified veterinarians about adverse effects in dogs resulting from injectable drug Librela. More Justin Sullivan/Getty Images Librela works by blocking the pain pathway from the ...

The AI-fo­cused biotech in­sitro is ad­vanc­ing a new idea to po­ten­tial­ly treat ALS, one of the most in­tractable and bru­tal dis­eases.